Healthcare

According to a market report by Lucintel, the future of the animal antibiotic and antimicrobial market looks promising with opportunities in the food-producing animal and companion animal segments. The global animal antibiotic and antimicrobial market is expected to reach an estimated $6.1 billion by 2028 with a CAGR of 4% from 2023 to 2028. The major drivers for this market are increasing demand for animal derived foods, growing cases of diseases among animals, and rising concern towards health of animals.



In this market, tetracycline, penicillin, sulfonamide, macrolide, aminoglycoside, lincosamide, fluoroquinolone, and cephalosporin are the major segments by product type. Lucintel forecasts that tetracycline will remain the largest product type segment over the forecast period because it ensures maximum efficacy against pathogenic germs and is less expensive than other animal antibiotics present in the market. 

Within this market, food producing animal is expected to remain the larger animal type segment due to the growing expenditure for veterinary treatment, rising spread of zoonotic diseases, and increasing need for nutritious animal feeding.



North America will remain the largest region due to the growing livestock production and increasing expenditure for the development of medicines to treat animal diseases in the region.

Boehringer Ingelheim, Zoetis, Elanco Animal Health, Merck, and Phibro Animal Health are the major suppliers in the global animal antibiotic and antimicrobial market. 



Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global animal antibiotic and antimicrobial market by product type, mode of delivery, animal type, and region. Lucintel has compiled a comprehensive research report entitled “Growth Opportunities in the Global Animal Antibiotic and Antimicrobial Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global animal antibiotic and antimicrobial market by product type, mode of delivery, animal type, and region, as follows:

 

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 

Q.1. What are some of the most promising, high-growth opportunities for the animal antibiotic and antimicrobial market by product type (tetracycline, penicillin, sulfonamide, macrolide, aminoglycoside, lincosamide, fluoroquinolone, cephalosporin, and others), mode of delivery (premixes, oral powder, oral solution, injection, and others), animal type (food-producing animals and companion animals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?